☰

Gustavo A. Mendoza-Fandino, Ph.D. - Publications

Affiliations: 
2013 Biochemistry and Molecular Biology University of Southern California, Los Angeles, CA, United States 
Area:
Genetics, Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Mendoza-Fandiño G, Lyra PCM, Nepomuceno TC, Harro CM, Woods NT, Li X, Rangel LB, Carvalho MA, Couch FJ, Monteiro ANA. Two distinct mechanisms underlie estrogen-receptor-negative breast cancer susceptibility at the 2p23.2 locus. European Journal of Human Genetics : Ejhg. PMID 34803163 DOI: 10.1038/s41431-021-01005-6  0.627
2018 Buckley MA, Woods NT, Tyrer JP, Mendoza-Fandiño G, Lawrenson K, Hazelett DJ, Najafabadi HS, Gjyshi A, Carvalho RS, Lyra PC, Coetzee SG, Shen HC, Yang AW, Earp MA, Yoder S, et al. Functional analysis and fine mapping of the 9p22.2 ovarian cancer susceptibility locus. Cancer Research. PMID 30487138 DOI: 10.1158/0008-5472.Can-17-3864  0.599
2017 Phelan CM, Kuchenbaecker KB, Tyrer JP, Kar SP, Lawrenson K, Winham SJ, Dennis J, Pirie A, Riggan MJ, Chornokur G, Earp MA, Lyra PC, Lee JM, Coetzee S, Beesley J, et al. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. Nature Genetics. PMID 28346442 DOI: 10.1038/ng.3826  0.369
2017 Harro CM, Mendoza-Fandino G, Woods NT, Li X, Couch FJ, Monteiro AN. Abstract 1306: Two distinct regulatory mechanisms underlie estrogen receptor negative breast cancer susceptibility at the 2p23.2 locus Epidemiology. 77: 1306-1306. DOI: 10.1158/1538-7445.Am2017-1306  0.344
2016 Permuth JB, Pirie A, Chen YA, Lin HY, Reid BM, Chen Z, Monteiro A, Dennis J, Mendoza-Fandino G, Anton-Culver H, Bandera EV, Bisogna M, Brinton L, et al. Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk. Human Molecular Genetics. PMID 27378695 DOI: 10.1093/Hmg/Ddw196  0.552
2016 Couch FJ, Kuchenbaecker KB, Michailidou K, Mendoza-Fandino GA, Nord S, Lilyquist J, Olswold C, Hallberg E, Agata S, Ahsan H, Aittomäki K, Ambrosone C, Andrulis IL, Anton-Culver H, Arndt V, et al. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer. Nature Communications. 7: 11375. PMID 27117709 DOI: 10.1038/Ncomms11375  0.444
2016 Buckley M, Gjyshi A, Mendoza-Fandiño G, Baskin R, Carvalho RS, Carvalho MA, Woods NT, Monteiro AN. Enhancer scanning to locate regulatory regions in genomic loci. Nature Protocols. 11: 46-60. PMID 26658467 DOI: 10.1038/Nprot.2015.136  0.513
2016 Gjyshi A, Mendoza-Fandino G, Woods N, Tyrer J, Lawrenson K, Buckley M, Shen H, Carvalho R, Seo J, Phelan C, Freedman M, Goode E, Sellers T, Gayther S, Pharoah P, et al. Abstract PR15: MYC distal enhancers underlie ovarian cancer susceptibility in the 8q24.21 locus. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-Pr15  0.63
2015 Baskin R, Woods NT, Mendoza-Fandiño G, Forsyth P, Egan KM, Monteiro AN. Functional analysis of the 11q23.3 glioma susceptibility locus implicates PHLDB1 and DDX6 in glioma susceptibility. Scientific Reports. 5: 17367. PMID 26610392 DOI: 10.1038/Srep17367  0.601
2015 Mendoza-Fandino GA, Woods N, Baskin R, Gjyshi A, Monteiro AN. Abstract 841: SNP-FEMS: a method to identify DNA binding proteins interacting with enhancer elements Cancer Research. 75: 841-841. DOI: 10.1158/1538-7445.Am2015-841  0.581
2015 Baskin R, Woods N, Mendoza-Fandino G, Forsyth P, Egan K, Monteiro A. Abstract 3951: Functional analysis of the 11q23.3 glioma susceptibility locus Cancer Research. 75: 3951-3951. DOI: 10.1158/1538-7445.Am2015-3951  0.633
2014 Biancolella M, Fortini BK, Tring S, Plummer SJ, Mendoza-Fandino GA, Hartiala J, Hitchler MJ, Yan C, Schumacher FR, Conti DV, Edlund CK, Noushmehr H, Coetzee SG, Bresalier RS, Ahnen DJ, et al. Identification and characterization of functional risk variants for colorectal cancer mapping to chromosome 11q23.1. Human Molecular Genetics. 23: 2198-209. PMID 24256810 DOI: 10.1093/Hmg/Ddt584  0.563
2014 Buckley MA, Shen HC, Mendoza-Fandino GA, Woods NT, Gjyshi A, French J, Lawrenson K, Song H, Tyrer J, Carvalho RS, Valle A, Chen A, Yoder S, Bloom G, Tsai Y, et al. Abstract 3285: Functional analysis of the 9p22 locus implicates the transcriptional regulation ofBNC2as a mechanism in ovarian cancer predisposition Cancer Research. 74: 3285-3285. DOI: 10.1158/1538-7445.Am2014-3285  0.607
2011 Mendoza-Fandino GA, Gee JM, Ben-Dor S, Gonzalez-Quevedo C, Lee K, Kobayashi Y, Hartiala J, Myers RM, Leal SM, Allayee H, Patel PI. A novel g.-1258G>A mutation in a conserved putative regulatory element of PAX9 is associated with autosomal dominant molar hypodontia. Clinical Genetics. 80: 265-72. PMID 21443745 DOI: 10.1111/J.1399-0004.2010.01529.X  0.307
Show low-probability matches.